Bio Impact Capital LLC Stoke Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
A detailed history of Bio Impact Capital LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 789,698 shares of STOK stock, worth $10.7 Million. This represents 1.75% of its overall portfolio holdings.
Number of Shares
789,698
Previous 693,988
13.79%
Holding current value
$10.7 Million
Previous $4.62 Million
94.21%
% of portfolio
1.75%
Previous 0.85%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
139Shares Held
57.6MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$73.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$73.1 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$69.3 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$62.7 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$59.2 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $533M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...